Clinical Research Directory
Browse clinical research sites, groups, and studies.
MitoQ Supplementation and Cardiovascular Function in Healthy Men and Women
Sponsor: University of Colorado, Denver
Summary
In this pilot study, the investigators will determine whether supplementation with a mitochondrial-targeted antioxidant (Mitoquinone (MitoQ)) improves mitochondrial function, left ventricular diastolic and vascular function.
Official title: Mitochondrial Targeted Antioxidant Supplementation and Diastolic Function in Healthy Men and Women
Key Details
Gender
All
Age Range
50 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
31
Start Date
2021-08-01
Completion Date
2030-08
Last Updated
2025-03-07
Healthy Volunteers
Yes
Conditions
Interventions
MITOQUINOL MESYLATE then placebo
MITOQUINOL MESYLATE then placebo: 'MITOQUINOL MESYLATE' administered twice daily for 4 weeks followed by a washout, then placebo capsule administered twice daily for 4 weeks. Capsules with active product contain 20 mg of 'MITOQUINOL MESYLATE'.
Placebo, then MITOQUINOL MESYLATE
'Placebo, then MITOQUINOL MESYLATE' : Placebo administered twice daily for 4 weeks followed by a washout, then 'MITOQUINOL MESYLATE' capsule administered twice daily for 4 weeks. Capsules with active product contain 20 mg of 'MITOQUINOL MESYLATE'.
Locations (1)
University of Colorado
Aurora, Colorado, United States